About this FactMed analysis covering adverse side effect reports of PROPIONATE patients who developed RASH.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 2 individuals taking PROPIONATE reported RASH to the FDA. A total of 13 PROPIONATE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between PROPIONATE and RASH. In doing so, we compare PROPIONATE with other drugs that cause RASH, to help you evaluate whether or not PROPIONATE causes RASH. Likewise, this page shows the most highly-reported side effects of PROPIONATE, so you can see if RASH ranks among PROPIONATE's most well-known side effects.
Summary Statistics
Reports of PROPIONATE causing RASH: 2
Reports of any side effect of PROPIONATE : 13
Percentage of PROPIONATE patients where RASH is a reported side effect: 15.3846%

FDA reports of any drug causing RASH : 80690
Average percentage for all medicated patients where RASH is reported as a complication: 0.5057%

Physician opinion on PROPIONATE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing PROPIONATE:
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
SLEEP APNOEA SYNDROME ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with RASH:

HUMIRA (4676 patients)
ASPIRIN (4350 patients)
LAMICTAL (4338 patients)
FOSAMAX (3376 patients)
REMICADE (2807 patients)
NEXAVAR (2758 patients)
LIPITOR (2299 patients)
PREDNISONE (2294 patients)
ENBREL (2243 patients)
METHOTREXATE (2100 patients)
SYNTHROID (1997 patients)
VIOXX (1985 patients)
LISINOPRIL (1913 patients)
LASIX (1833 patients)
REVLIMID (1817 patients)
NEXIUM (1731 patients)
CHANTIX (1658 patients)
FOLIC ACID (1645 patients)
PREDNISOLONE (1632 patients)
LYRICA (1592 patients)
RIBAVIRIN (1590 patients)
GLEEVEC (1490 patients)
OMEPRAZOLE (1467 patients)
ACCUTANE (1459 patients)
CELEBREX (1446 patients)
ACETAMINOPHEN (1438 patients)
PEGASYS (1428 patients)
HEPARIN SODIUM INJECTION (1400 patients)
SEROQUEL (1388 patients)
SIMVASTATIN (1368 patients)
NIASPAN (1358 patients)
ATENOLOL (1352 patients)
COUMADIN (1310 patients)
LEVOTHYROXINE SODIUM (1296 patients)
NORVASC (1267 patients)
XANAX (1248 patients)
TYSABRI (1243 patients)
NEURONTIN (1236 patients)
PLAVIX (1233 patients)
AVELOX (1208 patients)
ZOMETA (1208 patients)
HYDROCHLOROTHIAZIDE (1172 patients)
ALLOPURINOL (1172 patients)
BENADRYL (1167 patients)
CYMBALTA (1071 patients)
ZOLOFT (1069 patients)
DEXAMETHASONE (1066 patients)
AMBIEN (1065 patients)
LEXAPRO (1061 patients)
FUROSEMIDE (1045 patients)
IBUPROFEN (1039 patients)
LEVAQUIN (1038 patients)
TEGRETOL (1022 patients)
VITAMIN D (984 patients)
DIOVAN (975 patients)
ALBUTEROL (972 patients)
EXJADE (952 patients)
FORTEO (952 patients)
PRILOSEC (951 patients)
CRESTOR (938 patients)
ZOCOR (920 patients)
PREDNISONE TAB (918 patients)
ERBITUX (917 patients)
CALCIUM (912 patients)
OXYCONTIN (905 patients)
PAXIL (901 patients)
PROTONIX (890 patients)
TARCEVA (885 patients)
TOPROL-XL (877 patients)
PREVACID (865 patients)
ADVAIR DISKUS 100/50 (864 patients)
ZYRTEC (850 patients)
METFORMIN HCL (842 patients)
ATIVAN (840 patients)
LORAZEPAM (832 patients)
MAGNEVIST (810 patients)
GABAPENTIN (802 patients)
REBETOL (802 patients)
VICODIN (792 patients)
SPIRIVA (788 patients)
SINGULAIR (773 patients)
DECADRON (765 patients)
POTASSIUM CHLORIDE (762 patients)
AMLODIPINE (761 patients)
AMOXICILLIN (759 patients)
WARFARIN SODIUM (758 patients)
AREDIA (755 patients)
LANSOPRAZOLE (753 patients)
WELLBUTRIN (724 patients)
ALLEGRA (710 patients)
KLONOPIN (705 patients)
CLONAZEPAM (699 patients)
PEG-INTRON (689 patients)
PREMARIN (688 patients)
INCIVEK (679 patients)
PERCOCET (669 patients)
BEXTRA (662 patients)
VANCOMYCIN (661 patients)
ZOFRAN (659 patients)
METOPROLOL TARTRATE (658 patients)
MULTI-VITAMINS (656 patients)
EFFEXOR (648 patients)
DIGOXIN (642 patients)
LAMOTRIGINE (638 patients)
ALPRAZOLAM (635 patients)
ZANTAC (628 patients)
MULTI-VITAMIN (627 patients)
AVONEX (621 patients)
IRESSA (620 patients)
COPEGUS (616 patients)
BACTRIM (606 patients)
ERLOTINIB HYDROCHLORIDE (602 patients)
LANTUS (599 patients)
FISH OIL (596 patients)
OXYCODONE HCL (595 patients)
PROZAC (594 patients)
ACYCLOVIR (589 patients)
FLUOROURACIL (588 patients)
JANUVIA (585 patients)
ZITHROMAX (572 patients)
CYCLOPHOSPHAMIDE (570 patients)
AUGMENTIN '125' (563 patients)
CARBOPLATIN (547 patients)
TYKERB (543 patients)
XELODA (540 patients)
TRAZODONE HCL (535 patients)
VITAMIN B-12 (534 patients)
DURAGESIC-100 (532 patients)
CIPROFLOXACIN (532 patients)
ASCORBIC ACID (524 patients)
TRAMADOL HCL (522 patients)
DEPAKOTE (520 patients)
COREG (519 patients)
TASIGNA (517 patients)
MORPHINE (515 patients)
ZETIA (514 patients)
VALTREX (510 patients)
INSULIN (507 patients)
VOLTAREN (506 patients)
NO CONCURRENT MEDICATION (505 patients)
CELEXA (504 patients)
EPOGEN (503 patients)
CIMZIA (499 patients)
KEPPRA (497 patients)
FAMOTIDINE (490 patients)
TYLENOL (CAPLET) (482 patients)
WELLBUTRIN XL (480 patients)
METOPROLOL (479 patients)
TELAVIC (TELAPREVIR) (478 patients)
PROCRIT (471 patients)
FACTIVE (471 patients)
RISPERDAL (469 patients)
CLARITIN (465 patients)
VALIUM (465 patients)
RANITIDINE (458 patients)
ACTONEL (457 patients)
TOPAMAX (455 patients)
DIFLUCAN (452 patients)
TYLENOL (452 patients)
VELCADE (449 patients)
LORTAB (437 patients)
DIAZEPAM (437 patients)
LOXONIN (436 patients)
FLOMAX (434 patients)
OMNISCAN (433 patients)
PREDONINE (432 patients)
ALENDRONATE SODIUM (432 patients)
FLUCONAZOLE (431 patients)
CYCLOSPORINE (425 patients)
LOVENOX (424 patients)
NAPROXEN (419 patients)
VITAMIN E (414 patients)
ABILIFY (413 patients)
SPIRONOLACTONE (409 patients)
FLEXERIL (409 patients)
LEVOXYL (394 patients)
DEPAKENE (394 patients)
PANTOPRAZOLE (392 patients)
DOCETAXEL (391 patients)
FLONASE (390 patients)
BYETTA (389 patients)
NEUPOGEN (388 patients)
CALCIUM CARBONATE (387 patients)
ALDACTONE (387 patients)
BONIVA (384 patients)
CISPLATIN (383 patients)
FENTANYL (383 patients)
GLUCOPHAGE (383 patients)
COZAAR (381 patients)
METFORMIN (380 patients)
COMPAZINE (379 patients)
ALTACE (378 patients)
PEPCID (375 patients)
ZYPREXA (373 patients)
SUTENT (372 patients)
AVASTIN (371 patients)
ACTOS (371 patients)
DILANTIN (371 patients)
TRUVADA (369 patients)
CLONIDINE (366 patients)
COLACE (363 patients)
XOLAIR (363 patients)
CLARITHROMYCIN (363 patients)
MIRENA (359 patients)
SIMCOR (358 patients)
GLIPIZIDE (356 patients)
ARANESP (353 patients)
ENALAPRIL MALEATE (351 patients)
RAMIPRIL (350 patients)
SANDOSTATIN LAR (349 patients)
Most common side effects for patients taking PROPIONATE:
RASH (2 patients)
PNEUMONIA (2 patients)
DYSPNOEA (2 patients)
DIARRHOEA (2 patients)
BLOOD ALBUMIN DECREASED (1 patients)
BLOOD CALCIUM DECREASED (1 patients)
BRONCHIECTASIS (1 patients)
CANDIDIASIS (1 patients)
CHILLS (1 patients)
CLOSTRIDIAL INFECTION (1 patients)
CONDITION AGGRAVATED (1 patients)
CONFUSIONAL STATE (1 patients)
CYSTIC FIBROSIS LUNG (1 patients)
BLISTER (1 patients)
DISEASE COMPLICATION (1 patients)
DYSGEUSIA (1 patients)
ASTHENIA (1 patients)
EROSIVE OESOPHAGITIS (1 patients)
ERYTHEMA (1 patients)
FLUSHING (1 patients)
FUNGAL INFECTION (1 patients)
GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY (1 patients)
HIATUS HERNIA (1 patients)
HYPOKALAEMIA (1 patients)
HYPOXIA (1 patients)
IDIOPATHIC PULMONARY FIBROSIS (1 patients)
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION (1 patients)
INCORRECT DRUG ADMINISTRATION DURATION (1 patients)
INCORRECT STORAGE OF DRUG (1 patients)
INFLUENZA (1 patients)
INJURY (1 patients)
INTERSTITIAL LUNG DISEASE (1 patients)
LETHARGY (1 patients)
LUNG INFECTION (1 patients)
LYMPHADENOPATHY (1 patients)
MALAISE (1 patients)
MUCOSAL INFLAMMATION (1 patients)
OEDEMA PERIPHERAL (1 patients)
OESOPHAGEAL DISORDER (1 patients)
PAIN (1 patients)
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED (1 patients)
ACUTE RESPIRATORY FAILURE (1 patients)
PULMONARY EMBOLISM (1 patients)
PYODERMA (1 patients)
PYREXIA (1 patients)
ACTINIC KERATOSIS (1 patients)
RENAL FAILURE (1 patients)
RENAL FAILURE ACUTE (1 patients)
SOMNOLENCE (1 patients)
SPUTUM DISCOLOURED (1 patients)
STAPHYLOCOCCAL INFECTION (1 patients)
STENOTROPHOMONAS INFECTION (1 patients)
THROMBOCYTOPENIA (1 patients)
TONGUE COATED (1 patients)
TUMOUR LYSIS SYNDROME (1 patients)
VOMITING (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for PROPIONATE


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about RASH and PROPIONATE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking PROPIONATE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in PROPIONATE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for PROPIONATE experts. If you are a healthcare provider experienced in prescribing PROPIONATE, please register here.
giCould not connect: